AVAULTA PLUS BIOSYNTHETIC SUPPORT SYSTEM - ANTERIOR
Report
- Report Number
- 1018233-2012-02198
- Event Type
- Injury
- Date Received
- December 27, 2012
- Report Date
- October 29, 2015
- Manufacturer
- C.R. BARD, INC. (COVINGTON)
- Product Code
- FTL
- PMA / PMN Number
- K082571
- Removal / Correction Number
- NA
- Adverse Event
- Yes
- Report Source
- Manufacturer report
- Reporter Location
- MS, US
- Reporter Occupation
- ATTORNEY
- Health Professional
- N
Narratives
THE SAMPLE WAS NOT RETURNED. THE FINISHED PRODUCT MET ALL SPECIFICATIONS PRIOR TO BEING RELEASED FOR GENERAL DISTRIBUTION. THE INSTRUCTIONS FOR USE WHICH ACCOMPANIES ALL DEVICES CURRENTLY ADDRESSES POTENTIAL RISKS ASSOCIATED WITH SURGICALLY IMPLANTED MATERIALS. THE INSTRUCTIONS FOR USE STATES IN THE ADVERSE REACTIONS: "POTENTIAL ADVERSE REACTIONS ARE THOSE TYPICALLY ASSOCIATED WITH SURGICALLY IMPLANTABLE MATERIALS, INCLUDING HEMATOMA, SEROMA, MUCOSAL OR VISCERAL EROSION, INFECTION, INFLAMMATION, SENSITIZATION, DYSPAREUNIA, SCARIFICATION AND CONTRACTION, FISTULA FORMATION, EXTRUSION AND RECURRENCE OF VAGINAL WALL PROLAPSE. PERFORATIONS OR LACERATIONS OF VESSELS, NERVES, BLADDER, BOWEL, RECTUM, OR ANY VISCERA MAY OCCUR DURING NEEDLE PASSAGE." (B)(4).
THE PT'S ATTORNEY ALLEGED A DEFICIENCY AGAINST THE DEVICE. ADDITIONAL INFO HAS BEEN REQUESTED, BUT NOT YET RECEIVED. ASSOCIATED MDRS: 1018233-2012-02195, 1018233-2012-02196, AND 1018233-2012-02197.
Devices
| Seq | Brand | Generic | Product Code | Manufacturer | Model | Lot | UDI-DI |
|---|---|---|---|---|---|---|---|
| 1 | AVAULTA PLUS BIOSYNTHETIC SUPPORT SYSTEM - ANTERIOR | FTL | C.R. BARD, INC. (COVINGTON) | NA | CVRK0019 |
Patients
| Seq | Age | Sex | Outcome | Treatment |
|---|---|---|---|---|
| 1 | 51 YR | Female | Required Intervention | ALIGN TO URETHRAL SUPPORT SYSTEM| AVAULTA PLUS POSTERIOR| BIOSYNTHETIC SUPPORT SYSTEM| PELVISOFT ACELLULAR COLLAGEN BIOMESH| ALIGN TO URETHRAL SUPPORT SYSTEM| BIOSYNTHETIC SUPPORT SYSTEM| AVAULTA PLUS POSTERIOR| PELVISOFT ACELLULAR COLLAGEN BIOMESH |